JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.

Jiangxi Synergy Pharmaceutical Co., Ltd.

300636

CNE100002P83

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
10.25 ^CNY	-3.03%		-5.09%	-2.75%

24/04	Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24/04	Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Final Dividend for 2021

May 17, 2022 at 01:03 am IST

Jiangxi Synergy Pharmaceutical Co., Ltd. at its AGM held on May 13, 2022, approved final dividend of CNY 0.60000000 per 10 shares (tax included) for 2021.

Latest news about Jiangxi Synergy Pharmaceutical Co., Ltd.

Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24/04	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Jiangxi Synergy Pharmaceutical Co., Ltd.(XSEC:300636) added to S&P Global BMI Index	18/23/18	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	26/22/26	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. announced that it expects to receive CNY 1.1 billion in funding	01/22/01	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/22/27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	23/22/23	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	05/21/05	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Election Directors and Supervisors	24/21/24	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	15/21/15	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	01/21/01	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	26/20/26	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	26/20/26	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	16/20/16	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	27/20/27	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	28/19/28	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	15/19/15	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	22/19/22	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	18/19/18	CI
Jiangxi Synergy Pharmaceutical Co., Ltd. Approves Profit Distribution for the Year 2017; Approves Board Changes	11/18/11	CI

Chart Jiangxi Synergy Pharmaceutical Co., Ltd.

Duration

Period

Chart Jiangxi Synergy Pharmaceutical Co., Ltd.

More charts

Jiangxi Synergy Pharmaceutical Co Ltd is a pharmaceutical manufacturing company. The Company is engaged in research, development, production and sales of chemical raw materials and pharmaceutical intermediates. The Company's products are used in various types of drugs, including nervous system drugs, such as antiepileptic drugs and antiulcer drugs; non-steroidal anti-inflammatory analgesics; circulatory system drugs, such as antihypertensive drugs; mental disorders drugs, such as antidepressants Medicine; and anti-viral drugs. The company's products are sold to domestic and foreign markets, including Europe, North America and Japan.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangxi Synergy Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.25 CNY

Average target price

9.3 CNY

Spread / Average Target

-9.27%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD.	-2.75%	596M
ELI LILLY AND COMPANY	+32.09%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-1.34%	372B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+7.39%	294B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.49%	168B

Other Pharmaceuticals